1. Home
  2. PW vs AIDX Comparison

PW vs AIDX Comparison

Compare PW & AIDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

PW

Power REIT (MD)

N/A

Current Price

$6.51

Market Cap

2.5M

Sector

Real Estate

ML Signal

N/A

Logo 20/20 Biolabs Inc. Common Stock

AIDX

20/20 Biolabs Inc. Common Stock

N/A

Current Price

$0.19

Market Cap

2.9M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
PW
AIDX
Founded
1967
2000
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Precision Instruments
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.5M
2.9M
IPO Year
2011
2025

Fundamental Metrics

Financial Performance
Metric
PW
AIDX
Price
$6.51
$0.19
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
7.8K
★ 194.1K
Earning Date
11-17-2026
11-19-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 88.90
34.48
EPS
N/A
★ N/A
Revenue
$1,982,265.00
★ $2,045,133.00
Revenue This Year
N/A
$44.20
Revenue Next Year
N/A
$95.73
P/E Ratio
★ N/A
N/A
Revenue Growth
0.32
★ 16.71
52 Week Low
$0.50
$0.21
52 Week High
$12.92
$18.96

Technical Indicators

Market Signals
Indicator
PW
AIDX
Relative Strength Index (RSI) 41.65 27.37
Support Level $6.44 N/A
Resistance Level $7.76 $0.69
Average True Range (ATR) 0.38 0.02
MACD -0.00 0.00
Stochastic Oscillator 22.83 14.50

Price Performance

Historical Comparison
PW
AIDX

About PW Power REIT (MD)

Power REIT is an internally-managed real estate investment trust that owns a portfolio of real estate assets related to transportation, energy infrastructure and Controlled Environment Agriculture in the United States. Its assets consisted of approximately 112 miles of railroad infrastructure and related real estate which is owned by its subsidiary, approximately 447 acres of fee simple land leased to a utility scale solar power generating project with an aggregate generating capacity of approximately 82 Megawatts and approximately 82 acres of land with approximately 357,000 square feet of CEA properties in the form of greenhouses. The company invested in greenhouses for state-licensed cannabis and food cultivation.

About AIDX 20/20 Biolabs Inc. Common Stock

20/20 Biolabs Inc is a commercial stage diagnostics company with the core mission of developing and commercializing clinical laboratory tests for early disease detection and prevention and associated software that is powered by machine learning and real-world data to improve diagnostic accuracy and clinical utility. The company offers two OneTest lab products; OneTest for Cancer that inludes primary MCED blood test and revenue source post-COVID and OneTest for Longevity that consists of inflammatory biomarkers.

Share on Social Networks: